CXCL12 and hepatocellular carcinoma: A high expression of CXCR4, the receptor of CXCL12, has been identified to be associated with tumorigenesis, progression, the risk of metastasis, and the overall median survival in HCC, which is a validated selective target in HCC (Yang et al., 2019; Yang et al., 2020).